KAEF.JK
PT Kimia Farma (Persero) Tbk [KAEF.JK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
KAEF.JK Stock Summary
In the News
KAEF.JK Financial details
Company Rating
-
Market Cap
4982.04B
Income
-81.9B
Revenue
10187.72B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
11.56K
Optionable
No
Shortable
Yes
Earnings
15 Apr 2024
P/E
-78.41
Forward P/E
-
PEG
6.17
P/S
0.69
P/B
-
P/C
-
P/FCF
-6.04
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-14.69
EPS next Y
-
EPS next Q
-
EPS this Y
-131.2%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
5.2%
Revenue Q/Q
4.77%
EPS Q/Q
602.76%
-
-
-
-
SMA20
3.63%
SMA50
-25.02%
SMA100
-28.8%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-1%
ROC
0.07%
Gross Margin
38%
Oper. Margin
7%
Profit Margin
-1%
Payout
-22%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
685.0-1935.0
52W High
-76.23%
52W Low
-32.85%
RSI
59.31
Rel Volume
0.48
Avg Volume
5.78M
Volume
2.76M
Perf Week
9%
Perf Month
-9.8%
Perf Quarter
-
Perf Half Y
-33.33%
-
-
-
-
Beta
0.193
-
-
Volatility
11.61%, 33.13%
Prev Close
4.55%
Price
460
Change
5.02%
Company Profile
- Volume Average 5.78M
- Market Capitalization 4982.04B
- Employee 11.56K
- CEO Mr. David Utama
- Headquarters Jakarta,ID
- IPO Date 2001-07-05
-
Website
https://kimiafarma.co.id 
PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and sells generic, ethical, license and narcotic medicines, and over the counter medicines, health equipment, raw materials, medicines, medical devices, and cosmetics. In addition, the company distributes its products in drug to pharmacies, hospital pharmacy installation, medical center, and drug stores. The company was founded in 1817 and is headquartered in Jakarta, Indonesia.
